Clinical Trial: A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder

Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL




Official Title: A Blinded, Cross-Over Study to Evaluate the Safety and Efficacy of ARD-501 in Patients With Autism Spectrum Disorder

Brief Summary: This is a blinded, placebo controlled, cross-over trial evaluating the safety of two dose-levels of in subjects with ASD.